Binding-site geometry and flexibility in DC-SIGN demonstrated with surface force measurements

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 28, 2009, Pages 11524-11529

  Menon, Sindhu ^a   Rosenberg, Kenneth ^a,c   Graham, Sarah A ^b   Ward, Eliot M ^b   Taylor, Maureen E ^b   Drickamer, Kurt ^b   Leckband, Deborah E ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ETH ZURICH   (Switzerland)

Author keywords

Adhesion; Molecular recognition; Multivalent receptors; Pathogen selectivity

Indexed keywords

CARBOHYDRATE; CD209 ANTIGEN; GLYCAN; OLIGOSACCHARIDE;

ARTICLE; CELL ADHESION; DENDRITIC CELL; GEOMETRY; IMMOBILIZED CELL; PRIORITY JOURNAL;

ADHESIVENESS; BINDING SITES; CELL ADHESION MOLECULES; DENDRITIC CELLS; LECTINS, C-TYPE; LIPID BILAYERS; MODELS, MOLECULAR; OLIGOSACCHARIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE;

EID: 67650930919     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901783106     Document Type: Article

References (44)

1. Janeway C, Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197-216.
2. Cambi A, Figdor C (2005) Levels of complexity in pathogen recognition by C-type lectins. Curr Opin Immunol 17:345-351.
3. Appelmelk B, et al. (2003) Cutting edge: Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 170:1635-1639.
4. Geijtenbeek T, et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
5. Geijtenbeek T, et al. (2000) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-585.
6. Feinberg H, Mitchell D, Drickamer K, Weis W (2001) Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294:2163-2166.
7. Guo Y, et al. (2004) Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR Nat Struct Mol Biol 11:591-598.
8. Mitchell DA, Fadden AJ, Drickamer K (2001) A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 276:28939-28945.
9. Pohlmann S, Baribaud F, Doms R (2001) DC-SIGN and DC-SIGNR: Helping hands for HIV. Trends Immunol 22:643-646.
10. van Kooyk Y, Geijtenbeek T (2003) DC-SIGN: Escape mechanism for pathogens. Nat Rev Immunol 3:697-709.
11. Simmons G, et al. (2003) DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305:115-123.
12. Tassaneetrithep B, et al. (2003) DC-SIGN (CD209) mediates Dengue virus infection of human dendritic cells. J Exp Med 197:823-829.
13. Tailleux L, et al. (2003) DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197:121-127.
14. Geijtenbeek T, et al. (2000) DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 1:353-357.
15. Feinberg H, et al. (2005) Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 280:1327-1335.
16. Israelachvili J, Adams G (1978) Measurement of forces between two mica surfaces in aqueous electrolyte solutions in the range 0-100 nm. J Chem Soc Faraday Trans I 75:975-1001.
17. Israelachvili J (1992) Adhesion forces between surfaces in liquids and condensable vapours. Surf Sci Rep 14:110-159.
18. Israelachvili J (1973) Thin film studies using multiple-beam interferometry. J Colloid Interface Sci 44:259-272.
19. Weis WI, et al. (1991) Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science 254:1608-1615.
20. Wong J, et al. (1997) Direct measurement of a tethered ligand-receptor interaction potential. Science 275:820-822.
21. Chan P, et al. Influence of receptor lateral mobility on adhesion strengthening between membranes containing LFA-3 and CD2. J Cell Biol 115:245-255, 1991.
22. Leckband D, Schmitt F, Israelachvili J, Knoll W (1994) Direct force measurements of specific and nonspecific protein interactions. Biochemistry 33:4611-4624.
23. Rai P, et al. (2006) Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins. Nat Biotechnol 24:582-586.
24. Golumbfskie A, Pande V, Chakraborty A (1999) Simulation of biomimetic recognition between polymers and surfaces. Proc Natl Acad Sci USA 96:11707-11712.
25. Aisenbrey C, Bechinger B, Grobner G (2008) Macromolecular crowding at membrane interfaces: Adsorption and alignment of membrane peptides. J Mol Biol 375:376-385.
26. Johnson C, et al. (2003) Engineered protein A for the orientational control of immobilized proteins. Bioconjug Chem 14:974-978.
27. Soong R, Macdonald P (2007) PEG molecular weight and lateral diffusion of PEG-ylated lipids in magnetically aligned bicelles. Biochim Biophys Acta 1768:1805-1814.
28. Stankowski S (1983) Large-ligand adsorption to membranes II. Disc-like ligands and shape dependence at low saturation. Biochim Biophys Acta 735:352-360.
29. Lee RT, et al. (1991) Ligand-binding characteristics of rat serum-type mannose-binding protein (MBP-A): Homology of binding site architecture with mammalian and chicken hepatic lectins. J Biol Chem 266:4810-4815.
30. Weis W, Drickamer K (1994) Trimeric structure of a C-type mannose-binding protein. Structure (London) 2:1227-1240.
31. Dam TK, Brewer C (2008) Effects of clustered epitopes in multivalent ligand-receptor interactions. Biochemistry 47:8470-8476.
32. Bayas M, et al. (2007) Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58. J Biol Chem 282:5589-5596.
33. Holmskov U, Thiel S, Jensenius J (2003) Collections and ficolins: Humoral lectins of the innate immune defense. Annu Rev Immunol 21:547-578.
34. Kiessling L, Gestwicki J, Strong L (2006) Synthetic multivalent ligands as probes of signal transduction. Angew Chem Int Ed Engl 45:2348-2368.
35. Weis W, Drickamer K (1996) Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem 65:441-473.
36. Mourez M, et al. (2001) Designing a polyvalent inhibitor of anthrax toxin. Nat Biotechnol 19:958-961.
37. Kitov PI, et al. (2000) Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403:669-672.
38. Kitov PI, Bundle DR (2003) On the nature of the multivalency effect: A thermodynamic model. J Am Chem Soc 125:16271-16284.
39. Fan E, et al. (2000) High-affinity pentavalent ligands of Escherichia coli heat-labile enterotoxin by modular structure-based design. J Am Chem Soc 122:2663-2664.
40. Zhang Z, et al. (2002) Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin. J Am Chem Soc 124:12991-12998.
41. Marra J, Israelachvili J (1985) Direct measurements of forces between phosphatidylcholine and phosphatidylethanolamine bilayers in aqueous electrolyte solutions. Biochemistry 24:4608-4618.
42. Bartlett G (1959) Phosphorus assay in column chromatography. J Biol Chem 234:466-468.
43. Martel L, et al. (2002) X-ray reflectivity investigations of two-dimensional assemblies of C-cadherins: First steps in structural and functional studies. J Phys IV France 12:365-377.
44. Israelachvili J (1992) Intermolecular and Surface Forces (Academic, New York).